Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis

Giovanni Gambassi, Giovanna Niro, A Andriulli, G Leandro, A Mangia, Valeria Festa, Maria Roaria Villani, D Facciorusso, P Conoscitore, F Spirito, G De Maio

Research output: Contribution to journalArticle

172 Citations (SciVal)


The identification of therapeutic agents that can prevent the pancreatic injury after endoscopic retrograde cholangiopancreatography (ERCP) is of considerable importance.
Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalGastrointestinal Endoscopy
Publication statusPublished - 2000


  • Acute Disease
  • Amylases
  • Cholangiopancreatography, Endoscopic Retrograde
  • Gabexate
  • Hormones
  • Humans
  • Octreotide
  • Pain
  • Pancreas
  • Pancreatitis
  • Serine Proteinase Inhibitors
  • Somatostatin
  • Treatment Outcome


Dive into the research topics of 'Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis'. Together they form a unique fingerprint.

Cite this